Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics
Go back to Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics| (NASDAQ: FHTX) | Delayed: 3.50 -0.1 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.60 | 52 Week High | $ | |||
| Open | $3.61 | 52 Week Low | $ | |||
| Day High | $3.66 | P/E | N/A | |||
| Day Low | $3.47 | EPS | $ | |||
| Volume | 525,425 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 198.88 +4.06 (2.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $194.82 | 52 Week High | $0.52 | |||
| Open | $195.35 | 52 Week Low | $0.08 | |||
| Day High | $202.67 | P/E | N/A | |||
| Day Low | $192.51 | EPS | $-3.80 | |||
| Volume | 13,956,256 | |||||
| (NASDAQ: SANA) | Delayed: 2.95 -0.01 (0.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.96 | 52 Week High | $ | |||
| Open | $2.96 | 52 Week Low | $ | |||
| Day High | $3.00 | P/E | N/A | |||
| Day Low | $2.90 | EPS | $ | |||
| Volume | 2,880,336 | |||||

